Subconjunctival injection of tumor necrosis factor-α pre-stimulated bone marrow-derived mesenchymal stem cells enhances anti-inflammation and anti-fibrosis in ocular alkali burns

Graefes Arch Clin Exp Ophthalmol. 2021 Apr;259(4):929-940. doi: 10.1007/s00417-020-05017-8. Epub 2020 Nov 25.

Abstract

Purpose: To investigate the therapeutic effect of subconjunctival injection of tumor necrosis factor-α (TNF-α) pre-stimulated bone marrow-derived mesenchymal stem cells (BMMSCs) on ocular alkali burns in a rat model.

Methods: After applying a 6 mm filter paper soaking in 1 N NaOH on the cornea of rats, the suspension of TNF-α pre-stimulated BMMSCs, BMMSCs and PBS were given subconjunctivally and respectively. Corneal epithelial defect, corneal opacity, inflammation as well as PTGS2 and TSG-6 expression on day 7 and fibrosis on day 14 were compared.

Results: TNF-α pre-stimulated BMMSCs group had a more predominate effect on promoting corneal epithelial repairing, decreasing corneal opacity, reducing inflammatory cells and CD68 + macrophages on day 7 and suppressing fibrosis on day 14 compared to BMMSCs group. Besides, it had significant increased expressions of PTGS2 and TSG-6 in vitro. Pre-treated with Indomethacin revealed a reverse effect on above-mentioned changes.

Conclusion: Subconjunctival injection of TNF-α pre-stimulated BMMSCs enhanced anti-inflammatory and anti-fibrotic effect in ocular alkali burns, which was possibly though up regulation of PTGS2 and TSG-6 expression.

Keywords: Anti-fibrosis; Anti-inflammation; Bmmscs; Ocular alkali burns; TNF-α.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Bone Marrow
  • Burns, Chemical* / drug therapy
  • Fibrosis
  • Mesenchymal Stem Cells*
  • Rats
  • Tumor Necrosis Factor-alpha

Substances

  • Anti-Inflammatory Agents
  • Tumor Necrosis Factor-alpha